imatinib mesylate has been researched along with Cat Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonkobara, M | 1 |
| Baumgartner, C; Gleixner, KV; Gruze, A; Hadzijusufovic, E; Peter, B; Pickl, WF; Rebuzzi, L; Thaiwong, T; Valent, P; Willmann, M; Yuzbasiyan-Gurkan, V | 1 |
| Bonkobara, M; Fujino, Y; Isotani, M; Lachowicz, JL; Ono, K; Tamura, K; Washizu, T; Yagihara, H; Yamada, O | 1 |
| Backlund, B; Cianciolo, RE; Clubb, FJ; Cook, AK; Lees, GE | 1 |
| Huelsmeyer, MK; Katayama, R; Kurzman, ID; Marr, AK; Thamm, DH; Vail, DM | 1 |
| Bonkobara, M; Hikosaka, M; Isotani, M; Ono, K; Tamura, K; Washizu, T; Yagihara, H | 1 |
1 review(s) available for imatinib mesylate and Cat Diseases
| Article | Year |
|---|---|
Dysregulation of tyrosine kinases and use of imatinib in small animal practice.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Imatinib Mesylate; Neoplasms; src-Family Kinases | 2015 |
1 trial(s) available for imatinib mesylate and Cat Diseases
| Article | Year |
|---|---|
Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Benzamides; Cat Diseases; Cats; DNA Mutational Analysis; DNA, Neoplasm; Drug Evaluation, Preclinical; Exons; Imatinib Mesylate; Immunoglobulin D; Mastocytosis; Molecular Sequence Data; Mutation; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Treatment Outcome | 2010 |
4 other study(ies) available for imatinib mesylate and Cat Diseases
| Article | Year |
|---|---|
Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation.
Topics: Animals; Apoptosis; Base Sequence; Benzamides; Cat Diseases; Cats; Cell Proliferation; Dasatinib; DNA Primers; Exons; Female; Humans; Imatinib Mesylate; In Vitro Techniques; Male; Mast Cells; Mastocytosis, Systemic; Molecular Sequence Data; Mutation; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines; Staurosporine; Tandem Repeat Sequences; Thiazoles | 2009 |
Minimal change glomerulopathy in a cat.
Topics: Animals; Benzamides; Cat Diseases; Cats; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; Nephrosis, Lipoid; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2011 |
Imatinib mesylate inhibits platelet-derived growth factor activity and increases chemosensitivity in feline vaccine-associated sarcoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cat Diseases; Cats; Imatinib Mesylate; Mice; Mice, Nude; Neoplasms, Experimental; Piperazines; Platelet-Derived Growth Factor; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sarcoma; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured; Vaccines | 2004 |
Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Benzamides; Cat Diseases; Cats; Exons; Germ-Line Mutation; Imatinib Mesylate; Male; Mastocytosis, Systemic; Molecular Sequence Data; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tandem Repeat Sequences | 2006 |